Thrombophilic mutations among Southern Iranian patients with sickle cell disease: High prevalence of factor V Leiden

Journal of Thrombosis and Thrombolysis

Volumn 25, Issue 3, 2008, Pages 288-292

  Rahimi, Zohreh ^a   Vaisi Raygani, Asad ^a   Nagel, Ronald L ^b   Muniz, Adriana ^b  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Factor V Leiden; Iran; Prothrombin G20210A; Sickle cell disease

Indexed keywords

ADENINE; BLOOD CLOTTING FACTOR 5 LEIDEN; GUANINE; HEMOGLOBIN; PROTHROMBIN;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GENE MUTATION; GENOTYPE; HETEROZYGOSITY; HUMAN; IRAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SICKLE CELL ANEMIA; SICKLE CELL TRAIT; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; BETA-THALASSEMIA; BLOOD COAGULATION; CASE-CONTROL STUDIES; CHILD; FACTOR V; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HETEROZYGOTE; HUMANS; IRAN; LOGISTIC MODELS; MALE; MIDDLE AGED; MUTATION; ODDS RATIO; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTHROMBIN; RISK ASSESSMENT; SICKLE CELL TRAIT; THROMBOPHILIA;

EID: 44649106902     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-007-0069-x     Document Type: Article

References (16)

1. Almawi WY, Keleshian SH, Borgi L et al (2005) Varied prevalence of factor V G1691A (Leiden) and prothrombin G20210A single nucleotide polymorphisms among Arabs. J Thromb Thrombolys 20:163-168
2. Ataga KI, Orringer EP (2003) Hypercoagulability in sickle cell disease: a curious paradox. Am J Med 115:721-728
3. Rahimi Z, Merat A, Haghshenass M, Madani H, Rezaei M, Nagel RL (2006) Plasma lipids in Iranians with sickle cell disease: Hypocholesterolemia in sickle cell anemia and increase of HDL-cholesterol in sickle cell trait. Clin Chim Acta 365:217-220
4. Habibzadeh F, Yadollahie M, Ayatollahie M, Haghshenass M (1999) The prevalence of sickle cell syndrome in south of Iran. Irn J Med Sci 24:32-34
5. Otrock ZK, Mahfouz RAR, Taher AT (2005) Should we screen Eastern Mediterranean sickle beta-thalassemia patients for inherited thrombophilia? J Thromb Haemost 3:599-600
6. Isma'eel H, Shamseddeen AW, Mahfouz R, Zeineh N, Jradi O, Taher A (2006) Screening for inherited thrombophilia might be warranted among Eastern Mediterranean sickle-beta-0-thalassemia patients. J Thromb Thrombolys 22:121-123
7. Andrade FL, Annichino-Bizzacchi JM, Saad STO, Costa FF, Arruda VR (1998) Prothrombin mutant, factor V Leiden, and thermolabile variant of methylenetetrahydrofolate reductase among patients with sickle cell disease in Brazil. Am J Hematol 59:46-50
8. Fawaz NA, Bashawery L, Al-Sheikh I, Qatari A, Al-Othman SS, Almawi WY (2004) Factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations among patients with sickle cell disease in Eastern Saudi Arabia. Am J Hematol 76:307-309
9. Fairbanks VF, Klee GG (1994) Biochemical aspects of hematology. In: Burtis CA, Ashwood ER (eds) Tietz text book of clinical chemistry. W.B.Saunders, Philadelphia, pp 2041-2042
10. Old JM, Higgs DR (1983) Gene analysis. In: Weatherall DJ (ed) Methods in hematology. The thalassemias, vol 6. Churchill Livingstone, London, pp 74-101
11. Cai SP, Wall J, Kan WY, Chehab FF (1994) Reverse dot blot probes for the screening of β-thalassemia mutations in Asian and American Blacks. Hum Mutat 3:59-63
12. Bertina RM, Koeleman BPC, Koster T et al (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369:64-67
13. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698-3703
14. Zimmerman SA, Ware RE (1998) Inherited DNA mutations contributing to thrombotic complications in patients with sickle cell disease. Am J Hematol 59:267-272
15. Zeinali S, Duca F, Zarbakhsh B, Tagliabue L, Mannucci PM (2000) Thrombophilic Mutations in Iran. Thromb Haemost 83:351-352
16. Kahn JE, Veyssier-Belot C, Renier JL, de Mazancourt P, Peltier JY, de Raucourt E (2002) Recurrent thromboembolism in a patient with β-thalassemia major associated with double heterozygosity for factor V R506Q and prothrombin G20210A mutations. Blood Coagul Fibrin 13:461-463